Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Goldman: Hedge and mutual funds favour banking and healthcare over tech

Published 12/04/2023, 08:26 AM
Updated 12/04/2023, 08:30 AM
© Reuters. FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., September 28, 2023.  REUTERS/Brendan McDermid/File Photo

By Naomi Rovnick and Nell Mackenzie

LONDON (Reuters) - Leading hedge funds and mutual funds are betting on gains outside the tech sector in coming months, Goldman Sachs research shows.

The ten stocks currently most favoured by both do not include any of the so-called Magnificent Seven tech titans that now dominate the S&P 500 index, according to research by the investment bank's prime brokerage unit.

Instead, it said, the shared top picks Goldman identified from analysing more than $5 trillion worth of hedge fund and mutual fund holdings are mostly in financial and medical-related sectors.

The basket of ten shared favourites includes Mastercard (NYSE:MA), Visa (NYSE:V) and U.S. healthcare groups United Health, Kenvue (NYSE:KVUE) and Humana (NYSE:HUM).

After intense crowding into tech megacaps, the Magnificent 7 group that includes Microsoft (NASDAQ:MSFT), Amazon (NASDAQ:AMZN) and Facebook owner Meta Platforms (NASDAQ:META) accounted for 13% of hedge funds' long positions last month, Goldman found, twice their weight at the start of 2023.

Yet signs of tech fatigue have emerged in recent weeks as hedge funds became increasingly concerned about their vulnerability to the fortunes of a small group of richly-valued businesses.

Hedge funds sold the largest volume of U.S. tech and media stocks since July in the week to Nov. 24.

Mutual funds, meanwhile, have been lukewarm on the Magnificent Seven for much of this year.

Goldman also said the stocks it has identified as "shared favourites" of hedge funds and mutual funds over the past 10 years have largely outperformed the wider stock market.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Stocks that are constituents of both fund types' popular position baskets," the Goldman strategists wrote in their note to prime brokerage clients, "have beaten the S&P 500 in 60% of months since 2013".

Meanwhile, stocks that Goldman identified as both fund types' least favourite picks lagged the S&P benchmark index in 63% of months since 2013, the investment bank said.

Both hedge funds and mutual funds have underperformed the wider market year-to-date on average, Goldman found. US equity long-short funds have returned 8% while only 31% of large-cap mutual funds have beaten their market benchmarks.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.